Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05011370 · ClinicalTrials.gov registry record
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
A clinical trial, sponsored by Protara Therapeutics.
- Completed
- Registry status
- 80
- Enrollment target
NCT05011370: Completed study, sponsored by Protara Therapeutics.
NCT05011370 is a clinical trial that has completed, run by Protara Therapeutics. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05011370 has completed, sponsored by Protara Therapeutics.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This is a multi-center prospective cross-sectional observational study that will assess the prevalence of liver disease in patients dependent on parenteral nutrition (PN) for 4 or more days per week. Liver disease will be determined by the presence of choline deficiency, cholestasis (confirmed by elevated serum alkaline phosphatase (ALP) liver isoenzyme level), and steatosis (confirmed by magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF). The objective of this study is to investigate the presence/prevalence of liver disease in patients dependent on PN (≥4 days a week).
Primary Outcome
Choline deficiency is defined as plasma-free choline concentration less than 7 nmol/mL.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-08-23 |
| Est. Completion | 2023-06-29 |
What the finished NCT05011370 record still lists
NCT05011370 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05011370 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05011370 about?
NCT05011370 is a clinical study titled "Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition". This is a multi-center prospective cross-sectional observational study that will assess the prevalence of liver disease in patients dependent on parenteral nutrition (PN) for 4 or more days per week. Liver disease will be determined by the presence of choline deficiency, cholestasis (confirmed by el...
What is the current status of trial NCT05011370?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2021-08-23. Estimated completion is 2023-06-29.
Who is sponsoring clinical trial NCT05011370?
This trial is sponsored by Protara Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI